Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;11(5):366-374.
doi: 10.1007/s12265-018-9811-3. Epub 2018 May 29.

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Lingqun Ye  1 , Xuan Ni  1 , Zhen-Ao Zhao  1   2 , Wei Lei  1   2 , Shijun Hu  3   4
Affiliations
Review

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Lingqun Ye et al. J Cardiovasc Transl Res. 2018 Oct.

Abstract

In recent decades, cardiovascular diseases have become the greatest health threat to human beings, and thus it is particularly important to explore the subtle underlying pathogenesis of cardiovascular diseases. Although many molecular pathways have been explored to be essential in the development of cardiovascular diseases, their clinical significances are still uncertain. With the emergence of induced pluripotent stem cells (iPSCs), a unique platform for cardiovascular diseases has been established to model cardiovascular diseases on specific genetic background in vitro. This review summarizes current progresses of iPSCs in cardiovascular disease modeling and drug testing. This review highlighted iPSC-based cardiovascular disease modeling and drug testing. The technical advances in iPSC-based researches and various clinically relevant applications are discussed. With further intensive research, iPSC technology will shape the future of clinical translational research in cardiovascular diseases.

Keywords: Cardiovascular diseases; Disease modeling; Drug testing; Induced pluripotent stem cells.

PubMed Disclaimer

References

    1. J Pharmacol Toxicol Methods. 2012 Nov-Dec;66(3):246-56 - PubMed
    1. Cardiovasc Toxicol. 2015 Apr;15(2):127-39 - PubMed
    1. Cardiovasc Res. 2014 Nov 1;104(2):258-69 - PubMed
    1. J Am Coll Cardiol. 2014 Aug 5;64(5):451-9 - PubMed
    1. Adv Drug Deliv Rev. 2016 Jan 15;96:214-24 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources